{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:06:46Z","timestamp":1789229206286,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20GM103430"],"award-info":[{"award-number":["P20GM103430"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["OIA - 1655221"],"award-info":[{"award-number":["OIA - 1655221"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["-1655221"],"award-info":[{"award-number":["-1655221"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010428","name":"Rhode Island College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009614","name":"University of Rhode Island","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omton.2026.201230","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:46:34Z","timestamp":1778341594000},"page":"201230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["CpG 1018 augments mRNA vaccine-induced anti-tumor immunity by potentiating CD8+ T cell responses"],"prefix":"10.1016","volume":"34","author":[{"given":"Yibo","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayachandra Reddy","family":"Nakkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Labone","family":"Akter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinliang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuna","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"VanLuinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4735-3922","authenticated-orcid":false,"given":"Xinyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201230_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.omton.2026.201230_bib2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","article-title":"Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study","volume":"403","author":"Weber","year":"2024","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.omton.2026.201230_bib3","article-title":"Distant metastasis-free survival results from the randomized, phase 2 mRNA-4157-P201\/KEYNOTE-942 trial","volume":"41","author":"Weber","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.omton.2026.201230_bib4","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41586-025-10004-2","article-title":"Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC","volume":"651","author":"Sahin","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.omton.2026.201230_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omton.2026.201230_bib6","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.immuni.2022.05.007","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"55","author":"Alameh","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2026.201230_bib7","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2026.201230_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","article-title":"Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine","volume":"23","author":"Li","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omton.2026.201230_bib9","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/s41551-024-01256-w","article-title":"Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d","volume":"8","author":"Chaudhary","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.omton.2026.201230_bib10","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41586-024-08508-4","article-title":"RNA neoantigen vaccines prime long-lived CD8(+) T cells in pancreatic cancer","volume":"639","author":"Sethna","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.omton.2026.201230_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13273-021-00171-4","article-title":"Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency","volume":"18","author":"Kim","year":"2022","journal-title":"Mol. Cell. Toxicol."},{"key":"10.1016\/j.omton.2026.201230_bib12","article-title":"Flagellin co-expression potentiates mRNA vaccine-induced cytotoxic T lymphocyte responses but not anti-tumor immunity","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201230_bib13","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1021\/acs.nanolett.2c04883","article-title":"STING Agonist-Derived LNP-mRNA Vaccine Enhances Protective Immunity Against SARS-CoV-2","volume":"23","author":"Zhang","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.omton.2026.201230_bib14","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.ymthe.2021.03.002","article-title":"mRNA-encoded, constitutively active STING(V155M) is a potent genetic adjuvant of antigen-specific CD8(+) T cell response","volume":"29","author":"Tse","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201230_bib15","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41565-023-01404-4","article-title":"Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines","volume":"18","author":"Han","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omton.2026.201230_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2026.201230_bib17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/vaccines3020390","article-title":"CpG Oligonucleotides as Cancer Vaccine Adjuvants","volume":"3","author":"Shirota","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.omton.2026.201230_bib18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI23373","article-title":"Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909","volume":"115","author":"Speiser","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omton.2026.201230_bib19","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2003-04-1091","article-title":"CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8+ T-cell responses in vitro","volume":"103","author":"Rothenfusser","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.omton.2026.201230_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-4939-6445-1_2","article-title":"Development of the CpG Adjuvant 1018: A Case Study","volume":"1494","author":"Campbell","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omton.2026.201230_bib21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant","volume":"10","author":"Bode","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.omton.2026.201230_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12050531","article-title":"Differential Regulation of DC Function, Adaptive Immunity, and MyD88 Dependence by Two Squalene Emulsion-Based Vaccine Adjuvants","volume":"12","author":"Nakkala","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.omton.2026.201230_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omton.2026.201230_bib24","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature14426","article-title":"Mutant MHC class II epitopes drive therapeutic immune responses to cancer","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.omton.2026.201230_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12026-007-0066-3","article-title":"Modulation of NK cell activity by CpG oligodeoxynucleotides","volume":"39","author":"Ballas","year":"2007","journal-title":"Immunol. Res."},{"key":"10.1016\/j.omton.2026.201230_bib26","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/s41591-023-02432-2","article-title":"Precision medicine meets cancer vaccines","volume":"29","year":"2023","journal-title":"Nature medicine"},{"key":"10.1016\/j.omton.2026.201230_bib27","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41565-020-00782-3","article-title":"Proton-driven transformable nanovaccine for cancer immunotherapy","volume":"15","author":"Gong","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omton.2026.201230_bib28","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41467-025-56661-9","article-title":"Long-read sequencing of 945 Han individuals identifies structural variants associated with phenotypic diversity and disease susceptibility","volume":"16","author":"Gong","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201230_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq6541","article-title":"LITAF protects against pore-forming protein-induced cell death by promoting membrane repair","volume":"9","author":"Stefani","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.omton.2026.201230_bib30","doi-asserted-by":"crossref","first-page":"7903","DOI":"10.1038\/s41598-019-44263-7","article-title":"Bacterial flagellin promotes viral entry via an NF-kB and Toll Like Receptor 5 dependent pathway","volume":"9","author":"Benedikz","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201230_bib31","first-page":"17","article-title":"Dendritic cells: translating innate to adaptive immunity","volume":"311","author":"Steinman","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.omton.2026.201230_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(01)00455-X","article-title":"Regulation of T cell immunity by dendritic cells","volume":"106","author":"Lanzavecchia","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.omton.2026.201230_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.coi.2010.02.013","article-title":"Inflammatory cytokines as a third signal for T cell activation","volume":"22","author":"Curtsinger","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.omton.2026.201230_bib34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201230_bib35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.omton.2026.201230_bib36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.185.1.99","article-title":"Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1","volume":"185","author":"Sarafi","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omton.2026.201230_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1471-4906(00)01812-3","article-title":"RANTES: a versatile and controversial chemokine","volume":"22","author":"Appay","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.omton.2026.201230_bib38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201230_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1359-6101(02)00045-X","article-title":"Macrophage inflammatory protein-1","volume":"13","author":"Menten","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.omton.2026.201230_bib40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1189\/jlb.3RU0316-144R","article-title":"Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage","volume":"100","author":"Ushach","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.omton.2026.201230_bib41","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omton.2026.201230_bib42","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U","article-title":"Identification of CpG oligonucleotide sequences with high induction of IFN-alpha\/beta in plasmacytoid dendritic cells","volume":"31","author":"Krug","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omton.2026.201230_bib43","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41577-023-00837-1","article-title":"The biology of TREM receptors","volume":"23","author":"Colonna","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omton.2026.201230_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12032-018-1080-0","article-title":"The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma","volume":"35","author":"Uryvaev","year":"2018","journal-title":"Med. Oncol."},{"key":"10.1016\/j.omton.2026.201230_bib45","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer","volume":"102","author":"Sato","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2026.201230_bib46","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.18632\/oncotarget.3958","article-title":"CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome","volume":"6","author":"Huang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2026.201230_bib47","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4049\/jimmunol.157.5.1840","article-title":"Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA","volume":"157","author":"Ballas","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2026.201230_bib48","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41587-019-0247-3","article-title":"Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation","volume":"37","author":"Miao","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omton.2026.201230_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwad214","article-title":"STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy","volume":"10","author":"Zhou","year":"2023","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.omton.2026.201230_bib50","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/14760584.2018.1506332","article-title":"Combining vaccines and immune checkpoint inhibitors to prime, expand, and facilitate effective tumor immunotherapy","volume":"17","author":"Collins","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.omton.2026.201230_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120030","article-title":"Improving immunogenicity and safety of flagellin as vaccine carrier by high-density display on virus-like particle surface","volume":"249","author":"Zhao","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.omton.2026.201230_bib52","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1158\/1078-0432.CCR-11-2654","article-title":"Improved efficacy of dendritic cell-based immunotherapy by cutaneous laser illumination","volume":"18","author":"Chen","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201230_bib53","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144627","article-title":"Vaccine delivery alerts innate immune systems for more immunogenic vaccination","volume":"6","author":"Li","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.omton.2026.201230_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100051","article-title":"Single-Cell Isolation from Regenerating Murine Muscles for RNA-Sequencing Analysis","volume":"1","author":"Oprescu","year":"2020","journal-title":"STAR Protoc."},{"key":"10.1016\/j.omton.2026.201230_bib55","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1038\/s41467-018-06151-y","article-title":"Augmentation of vaccine-induced humoral and cellular immunity by a physical radiofrequency adjuvant","volume":"9","author":"Cao","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201230_bib56","doi-asserted-by":"crossref","first-page":"21872","DOI":"10.1021\/acsami.2c01028","article-title":"Flagellin\/Virus-like Particle Hybrid Platform with High Immunogenicity, Safety, and Versatility for Vaccine Development","volume":"14","author":"Zhao","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.omton.2026.201230_bib57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-9167-9_8","article-title":"Isolation of Tumor-Infiltrating Lymphocytes by Ficoll-Paque Density Gradient Centrifugation","volume":"1960","author":"Tan","year":"2019","journal-title":"Methods Mol. Biol."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926001062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926001062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:23:04Z","timestamp":1783326184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926001062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2950329926001062"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201230","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CpG 1018 augments mRNA vaccine-induced anti-tumor immunity by potentiating CD8+ T cell responses","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201230"}}